FindTrial
Sign In

Comparative safety and effectiveness of zoledronic acid versus denosumab in osteoporosis patients with vertebral compression fracture

Comparative safety and effectiveness of zoledronic acid versus denosumab in osteoporosis patients with vertebral compression fracture

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005424
Enrollment
80
Registered
2020-09-23
Start date
2020-01-02
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Osteoporotic compression fracture of the thoraco-lumbar spine 2. No history of previous treatment of osteoporosis 3. Patients who voluntarily joined the study

Exclusion criteria

Exclusion criteria: 1. Contraindication of drug treatment

Design outcomes

Primary

MeasureTime frame
Recurrence of compression fracture, Degree of improvement of bone mineral density, Complication—

Secondary

MeasureTime frame
Degree of improvement of bone mineral density, Complication—

Countries

Korea, Republic of

Contacts

Public ContactSeong Son

Gachon University Gil Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026